Author:
Muir Andrew J.,Arora Sanjeev,Everson Gregory,Flisiak Robert,George Jacob,Ghalib Reem,Gordon Stuart C.,Gray Todd,Greenbloom Susan,Hassanein Tarek,Hillson Jan,Horga Maria Arantxa,Jacobson Ira M.,Jeffers Lennox,Kowdley Kris V.,Lawitz Eric,Lueth Stefan,Rodriguez-Torres Maribel,Rustgi Vinod,Shemanski Lynn,Shiffman Mitchell L.,Srinivasan Subasree,Vargas Hugo E.,Vierling John M.,Xu Dong,Lopez-Talavera Juan C.,Zeuzem Stefan
Reference43 articles.
1. Vertex Pharmaceuticals I. INCIVEK™ (telaprevir) Prescribing Information; 2012.
2. Merck Sharp & Dohme Corp. VICTRELISTM (boceprevir) [package insert]; 2013.
3. Janssen Therapeutics. OLYSIO™ (simeprevir) Prescribing Information; 2014.
4. Food and Drug Administration. SOVALDI™ (sofosbuvir) Prescribing Information; 2014.
5. Gaps in the achievement of effectiveness of HCV treatment in national VA practice;Kramer;J Hepatol,2012
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献